Liver retransplantation associated with kidney transplantation for end stage liver graft disease and renal insufficiency: a morbid procedure on a unique subgroup of patients.
Chronic renal disease (CKD) jeopardizes the long-term outcomes of liver transplant recipients. In patients with end-stage liver graft disease and CKD, liver retransplantation associated with kidney transplantation (ReLT-KT) might be necessary. Yet, this specific subset of patients remains poorly described. Indications, perioperative characteristics, and short and long-term outcomes of patients undergoing ReLT-KT at 2 transplantation units from 1994 to 2012, were analyzed. Risk factors for postoperative mortality and long-term survivals were evaluated. Among 3060 patients undergoing liver transplantation (LT), 45 (1.5%) underwent ReLT-KT. The proportion of ReLT-KT among LT recipients continuously grew throughout the study period from 0.3% to 2.4% (p<0.001). Median time from primary LT to ReLT-KT was 151.3 (7.5-282.9) months. The most frequent indications for liver retransplantation were recurrence of the primary liver disease and cholangitis in 15 (33.3%) cases each. CKD was related to calcineurin inhibitors toxicity in 38 (84.4%) cases. Twelve (26.7%) patients died postoperatively. D-MELD (donor age*recipients' MELD) was associated with postoperative mortality (HR: 8.027; 95% CI: 2.387-18.223; p=0.026) and optimal cut-off value was 1039 (AUC: 0.801; p=0.002). Overall 1, 3 and 5 years survivals were 68.8%, 65.9% and 59.5%, respectively. D-MELD > 1039 was the only factor associated with poor survival (p=0.021). ReLT-KT is a highly morbid increasingly performed procedure. Refinements in the selection of grafts and transplant candidates are required in order to limit the postoperative mortality of these patients.